410 related articles for article (PubMed ID: 22437211)
1. Vasodilating versus first-generation β-blockers for cardiovascular protection.
Fares H; Lavie CJ; Ventura HO
Postgrad Med; 2012 Mar; 124(2):7-15. PubMed ID: 22437211
[TBL] [Abstract][Full Text] [Related]
2. An in-depth analysis of vasodilation in the management of hypertension: focus on adrenergic blockade.
Bakris G
J Cardiovasc Pharmacol; 2009 May; 53(5):379-87. PubMed ID: 19454898
[TBL] [Abstract][Full Text] [Related]
3. The vasodilatory beta-blockers.
Pedersen ME; Cockcroft JR
Curr Hypertens Rep; 2007 Aug; 9(4):269-77. PubMed ID: 17686376
[TBL] [Abstract][Full Text] [Related]
4. The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.
Black HR; Greenberg BH; Weber MA
Am J Med; 2010 Nov; 123(11):S2. PubMed ID: 21035578
[TBL] [Abstract][Full Text] [Related]
5. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
6. Effect of carvedilol and nebivolol on oxidative stress-related parameters and endothelial function in patients with essential hypertension.
Zepeda RJ; Castillo R; Rodrigo R; Prieto JC; Aramburu I; Brugere S; Galdames K; Noriega V; Miranda HF
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):309-16. PubMed ID: 22703478
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers for hypertension: are they going out of style?
Che Q; Schreiber MJ; Rafey MA
Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
[TBL] [Abstract][Full Text] [Related]
8. β-blockers: a review of their pharmacological and physiological diversity in hypertension.
Ripley TL; Saseen JJ
Ann Pharmacother; 2014 Jun; 48(6):723-33. PubMed ID: 24687542
[TBL] [Abstract][Full Text] [Related]
9. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockers in the treatment of hypertension: new data, new directions.
Weber MA; Bakris GL; Giles TD; Messerli FH
J Clin Hypertens (Greenwich); 2008 Mar; 10(3):234-8. PubMed ID: 18326967
[No Abstract] [Full Text] [Related]
11. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J; Faülhaber HD
Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers in the management of hypertension: focus on nebivolol.
Wojciechowski D; Papademetriou V
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):471-9. PubMed ID: 18402537
[TBL] [Abstract][Full Text] [Related]
13. What is the role, if any, for beta-blockers as initial therapy for uncomplicated hypertension?
Pedersen ME; Cockcroft JR
Curr Opin Cardiol; 2009 Jul; 24(4):325-32. PubMed ID: 19417638
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
16. Influence of salt intake on the antihypertensive effect of carvedilol.
Ruilope LM; Lahera V
J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
[TBL] [Abstract][Full Text] [Related]
17. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
18. Use of carvedilol in hypertension: an update.
Leonetti G; Egan CG
Vasc Health Risk Manag; 2012; 8():307-22. PubMed ID: 22661898
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
DiNicolantonio JJ; Hackam DG
Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Giancola A; Antonucci E
Curr Diabetes Rev; 2010 Jul; 6(4):215-21. PubMed ID: 20459394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
